These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3712080)

  • 21. Cerebral edema following iodine-131 therapy for thyroid carcinoma metastatic to the brain.
    Datz FL
    J Nucl Med; 1986 May; 27(5):637-40. PubMed ID: 3712081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Principles of radionuclide methods of diagnosing and treating primary thyroid cancer and its metastases].
    Purizhanskiĭ II; Lushina LI; Lyzhina VD; Lisenkov PI
    Med Radiol (Mosk); 1982 Oct; 27(10):61-6. PubMed ID: 7176859
    [No Abstract]   [Full Text] [Related]  

  • 23. Gallbladder visualization during post-therapy iodine-131 imaging of thyroid carcinoma.
    Achong DM; Oates E; Lee SL; Doherty FJ
    J Nucl Med; 1991 Dec; 32(12):2275-7. PubMed ID: 1744714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Follow-up of patients with differentiated thyroid cancer: determination of serum thyroglobulin in place of routine 131I scintigraphy?].
    Schatz H; Grebe SF; Horn W; Müller H
    Wien Klin Wochenschr; 1984 May; 96(10):389-93. PubMed ID: 6475061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The low utility of pretherapy scans in thyroid cancer patients.
    Schlumberger MJ; Pacini F
    Thyroid; 2009 Aug; 19(8):815-6. PubMed ID: 19645614
    [No Abstract]   [Full Text] [Related]  

  • 26. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer.
    Maxon HR; Thomas SR; Hertzberg VS; Kereiakes JG; Chen IW; Sperling MI; Saenger EL
    N Engl J Med; 1983 Oct; 309(16):937-41. PubMed ID: 6621620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma.
    Sherman SI; Tielens ET; Sostre S; Wharam MD; Ladenson PW
    J Clin Endocrinol Metab; 1994 Mar; 78(3):629-34. PubMed ID: 8126134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scintigraphy and treatment of medullary carcinoma of the thyroid with iodine-131 metaiodobenzylguanidine.
    Clarke SE; Lazarus CR; Edwards S; Murby B; Clarke DG; Roden TM; Fogelman I; Maisey MN
    J Nucl Med; 1987 Dec; 28(12):1820-5. PubMed ID: 3681441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Value of posttherapeutic scintigraphy for the demonstration of distant metastases of differentiated carcinomas of the thyroid gland].
    Moser E; Hahn D; Wendt T; Büll U
    Strahlentherapie; 1983 Apr; 159(4):217-23. PubMed ID: 6857735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine.
    Wang W; Larson SM; Tuttle RM; Kalaigian H; Kolbert K; Sonenberg M; Robbins RJ
    Thyroid; 2001 Dec; 11(12):1169-75. PubMed ID: 12186505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the therapeutic dose and diagnostic dose of 131I in the detection of metastatic foci of differentiated thyroid cancer.
    Tung CC; Chang TC; Su CT; Chen FW; Chang CC
    Taiwan Yi Xue Hui Za Zhi; 1988 Nov; 87(11):1081-5. PubMed ID: 3235967
    [No Abstract]   [Full Text] [Related]  

  • 32. Failure of low doses of 131I to ablate residual thyroid tissue following surgery for thyroid cancer.
    Kuni CC; Klingensmith WC
    Radiology; 1980 Dec; 137(3):773-4. PubMed ID: 7444061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroglobulin radioimmunoassay and 131I scintigraphy in patients with differentiated thyroid carcinoma.
    Lindegaard MW; Paus E; Høie J; Kullman G; Stenwig AE
    Acta Chir Scand; 1988 Feb; 154(2):141-5. PubMed ID: 3354295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Papillary cancer of the thyroid: biological behaviour and therapeutic planning (author's transl)].
    Spreafico G; Colombo L; Puricelli G
    Radiol Med; 1978 Sep; 64(9):1005-20. PubMed ID: 749025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Increased sensitivity of whole-body scintigraphy with I131 for the detection of iodine-accumulating metastases by means of delayed imaging].
    Briele B; Hotze A; Grünwald F; Overbeck B; Biersack HJ
    Nuklearmedizin; 1990 Dec; 29(6):264-8. PubMed ID: 2075087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
    Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
    J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unusual uptake of radioiodine in the chest in a patient with thyroid carcinoma.
    Nair N; Basu S; Pakhale H
    Br J Radiol; 2004 Jan; 77(913):63-7. PubMed ID: 14988142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Metastatic differentiated thyroid cancer. Diagnostic accuracy of thyroglobulin-RIA in comparison with 131I-whole body scintigraphy].
    Reiners C; Reimann J; Schäffer R; Baum K; Becker W; Eilles C; Gerhards W; Schick F; Spiegel W; Wiedemann W
    Rofo; 1984 Sep; 141(3):306-13. PubMed ID: 6435198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic visualization on iodine-131 whole-body thyroid cancer scans.
    Ziessman HA; Bahar H; Fahey FH; Dubiansky V
    J Nucl Med; 1987 Sep; 28(9):1408-11. PubMed ID: 3625293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iodine-131 contamination from thyroid cancer patients.
    Ibis E; Wilson CR; Collier BD; Akansel G; Isitman AT; Yoss RG
    J Nucl Med; 1992 Dec; 33(12):2110-5. PubMed ID: 1460501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.